Frates MC et al. (2005) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement - thyroid nodule shape and prediction of malignancy. Radiology 237: 794-800
Frates MC et al. (2005) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement - thyroid nodule shape and prediction of malignancy. Radiology 237: 794-800
4
33750474462
Current status of fine needle aspiration for thyroid nodules
Ogilvie JB et al. (2006) Current status of fine needle aspiration for thyroid nodules. Adv Surg 40: 223-238
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer
Mazzaferri EL et al. (2001) Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86: 1447-1463
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: A clinicopathologic study of 183 patients
Volante M et al. (2004) Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: A clinicopathologic study of 183 patients. Cancer 100: 950-957
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: A clinicopathologic study of 58 patients
Hiltzik D et al. (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: A clinicopathologic study of 58 patients. Cancer 106: 1286-1295
Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma
Robbins RJ et al. (2004) Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. J Clin Endocrinol Metab 89 6010-6016
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer
Lind P et al. (2006) Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med 36: 194-205
Patient-specific dosimetry for 1311 thyroid cancer therapy using 1241 PET and 3-dimensional-internal dosimetry (3D-ID) software
Sgouros G et al. (2004) Patient-specific dosimetry for 1311 thyroid cancer therapy using 1241 PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 45: 1366-1372